Clinical Study On Type Ⅲ Dampness-heat And Blood Stasis Prostatitis Treated By Acupuncture+Biofeedback

Objective To comprehensively evaluate the clinical efficacies through applying the α-receptor blocker,acupuncture+α-receptor blocker,biofeedback+a-receptor blocker treatment,acupuncture+biofeedback+α-receptor blocker treatment on type III chronic prostatitis,to provide the theoretical basis for the clinical treatment of dampness-heat and blood stasis type III prostatitis.Methods 160 cases of dampness-heat and blood stasis type Ⅲ prostatitis patients admitted in the Urinary Surgery and Andrology Clinic in the affiliated Jiaxing Hospital of Zhejiang University of Traditional Chinese Medicine were selected from January 1st 2012 to December 31st 2015;They were divided into 4 groups:group A(α-receptor blocker group);group B(acupuncture+α-receptor blocker group);group C(biofeedback+α-receptor blocker group);group D(acupuncture+biofeedback+α-receptor blocker group),with 40 cases in each group.The Chinese medical syndrome scores,NIH-CPSI scores,laboratory examinations and physical examinations of the patients in all groups were treated before the treatment,during the treatment(14 ± 3 d)and after the treatment(28 ± 3 d).The single α-receptor blocker was applied in the control group.The clinical efficacies of type Ⅲ chronic prostatitis in all groups were objectively evaluated through statistical analysis.Results 160 cases of dampness-heat and blood stasis type Ⅲ prostatitis patients were included in this study and randomly divided into four groups,with 40 cases in each group.Finally,a total of 146 cases were completed,including 36 completed cases,2 excluded cases and 2 cases out of touch in group A(α-receptor blocker group);38 completed cases,1 excluded case and 1 case out of touch in group B(acupuncture+α-receptor blocker group);37 completed cases,1 excluded case and 2 cases out of touch in group C(biofeedback+α-receptor blocker group);35 completed cases,1 excluded case and 4 cases out of control in group D(acupuncture± biofeedback+α-receptor blocker group).A total of 146 patients were included in the final statistics.As for the efficacy of NIH-CPSI and Chinese medical syndromes,suggesting that the efficacy of group D(acupuncture+biofeedback+α-receptor blocker group)was superior to that of group A(α-receptor blocker group)、group B(acupuncture+α-receptor blocker group)and group C(biofeedback+α-receptor blocker group).There was no significant difference in the efficacy between group B(acupuncture+α-receptor blocker group)and group C(biofeedback+α-receptor blocker group).The Chinese medical syndrome scores and NIH-CPSI scores in four groups of patients showed statistical significance before and after the treatment(P<0.001),suggesting that α-receptor blocker,acupuncture+α-receptor blocker,biofeedback+α-receptor blocker group and acupuncture+biofeedback+α-receptor blocker were valid to type Ⅲ prostatitis;After the treatment.The NIH-CPSI scores and Chinese medical syndrome scores showed statistical significance before and after the treatment,group D(acupuncture+biofeedback+α-receptor blocker group)were significantly decreased than those of group A(α-receptor blocker group)、group B(acupuncture+α-receptor blocker group)and group C(biofeedback+α-receptor blocker group)(P<0.05),group B(acupuncture+α-receptor blocker group)and group C(biofeedback+α-receptor blocker group)were decreased significantly than those of group A(α-receptor blocker group)(P<0.05).The NIH-CPSI scores and Chinese medical syndrome scores showed no significant difference between group B(acupuncture+α-receptor blocker group)and group C(biofeedback+α-receptor blocker group)(P>0.05).The NIH-CPSI score data in four groups of patients were analyzed.The result showed that pain,urination and life impact score showed statistical significance before and after treatment(P<0.001),suggesting that the α-receptor blocker、acupuncture+α-receptor blocker、biofeedback+α-receptor blocker and acupuncture+biofeedback+α-receptor blocker were valid in the treatment of pain,urination and life impact score of type Ⅲprostatitis patients.Conclusion(1).The α-receptor blocker、acupuncture+α-receptor blockeα、biofeedback+α-receptor blocker and acupuncture+biofeedback+α-receptor blocker had a certain curative in reduce NIH-CPSI,Chinese medical syndrome scores,improve symptoms,improve the quality of the dampness-heat and blood stasis type Ⅲ prostatitis patient.(2).The efficiency of acupuncture+biofeedback+α-receptor blocker was superior to that of acupuncture+ α-receptor blocker,biofeedback+α-receptor blocker and simple α-receptor blocker treatment.The efficiency of acupuncture+α-receptor blocker and biofeedback+α-receptor blocker was superior to that of simple α-receptor blocker treatment.(3).In terms of safety,there was no adverse reaction in four groups during the treatment,suggesting that the securities of four treatment methods were deserved in the treatment of dampness-heat and blood stasis type Ⅲ prostatitis.